MDM2 Antagonists Synergize Broadly and Robustly With Compounds Targeting Fundamental Oncogenic Signaling Pathways
Oncotarget - United States
doi 10.18632/oncotarget.1918
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 23, 2014
Authors
Publisher
Impact Journals, LLC